ProfessorMichael Kassiou
Professor
Faculty of Science
Research projects & supervision summary
Project Opportunities
Title: Drug Discovery and Medicinal Chemistry for the Central Nervous System
Summary of opportunity:
Projects involve developing novel CNS drugs through applications of organic synthesis, medicinal chemistry and pharmacological screening.
Opportunity synopsis:
Research is interdisciplinary and built around the key themes of medicinal chemistry and drug discovery. In this domain understanding drug-protein and drug-binding site interactions is a key component which allows us to obtain structure-activity relationships of bioactive CNS molecules and therefore the rational design of more efficacious treatments for diseases of the brain We have an extensive medicinal chemistry program evaluating structure-activity relationships of a number of molecules varying from polycyclic to heterocyclic scaffolds that interact with specific targets we think are involved in brain disease. The purpose of these studies is to identify lead molecules that can be further developed into drug candidates for the treatment of disease. These projects involve the synthesis of a series a compounds that aid in the identification of structural motifs responsible for optimizing activity. There are opportunities for exciting and challenging PhD projects in: (1) The design and synthesis of new molecular entities for neuronal and non-neuronal cells; (2) Development of structure-activity relationships of bioactive molecules; (3) Use of novel molecules for studies of receptor biology; (4) Applications of radiolabelled CNS active drugs.
----------Current Research Projects----------
For current research activities and opportunities please visit our home page: Research Group Website
RESEARCH PROJECTS & ACTIVITIES
- RESEARCH-BASED DEGREE SUPERVISIONAnalytical Pharmacology and Drug Discovery of the Oxytocin Receptor: Towards Ameliorating Neuropsychiatric Disorders and the Global Burden of Disease
- RESEARCH-BASED DEGREE SUPERVISIONBoron as a platform for small molecule IDO1 inhibitors
- RESEARCH-BASED DEGREE SUPERVISIONBoron in Drug Discovery
- RESEARCH-BASED DEGREE SUPERVISIONCharacterising senescence in iPSC-derived glial cells from amyotrophic lateral sclerosis patients expressing the C9orf72 mutation
- RESEARCH-BASED DEGREE SUPERVISIONChasing P2X7 Receptor Ligands for Cardiovascular Disease
- RESEARCH-BASED DEGREE SUPERVISIONCubane as a 3D scaffold for fragment library construction
- RESEARCH-BASED DEGREE SUPERVISIONDesign and Development of New Ligands for Imaging P2Y12
- RESEARCH-BASED DEGREE SUPERVISIONDesign and development of senolytic compounds for the treatment of neurodegenerative diseases.
- RESEARCH-BASED DEGREE SUPERVISIONDesign and synthesis of TSPO ligands as novel anxiolytic therapeutics
- RESEARCH-BASED DEGREE SUPERVISIONDeveloping a Novel Pharmacotherapy to Target the Inflammatory Contribution of Cardiovascular Disease
- RESEARCH-BASED DEGREE SUPERVISIONDevelopment of a new potential treatment for the deadly brain cancer glioblastoma
- RESEARCH-BASED DEGREE SUPERVISIONDevelopment of selective p38γ activators for the treatment of Alzheimer’s Disease
- RESEARCH-BASED DEGREE SUPERVISIONDevelopment of vascularised human brain cell co-cultures to improve translation in Alzheimer’s disease drug discovery
- RESEARCH-BASED DEGREE SUPERVISIONExpanding the Scope of CNS Drug Discovery
- RESEARCH-BASED DEGREE SUPERVISIONExploration of Novel Chemotypes that Ameliorate Cellular Senescence
- RESEARCH-BASED DEGREE SUPERVISIONExploration of Novel Mechanically Interlocked Drug Molecules
- RESEARCH-BASED DEGREE SUPERVISIONExploring molecules that ameliorate social dysfunction
- RESEARCH-BASED DEGREE SUPERVISIONFragment-based drug design approach for chemical modulators of a novel cardiovascular target
- RESEARCH-BASED DEGREE SUPERVISIONFrom recombinant proteins to cells: targeting TDP-43 in preclinical ALS and FTD therapeutic development
- RESEARCH-BASED DEGREE SUPERVISIONGenerating improved cellular models of neurodegenerative disease
- RESEARCH-BASED DEGREE SUPERVISIONIdentification of Novel Modulators for Neurodegenerative Disease States
- RESEARCH-BASED DEGREE SUPERVISIONInvestigating Endosomal Signaling of the Oxytocin Receptor and Its Potential for Pharmacological Targeting in the Treatment of Social Dysfunction
- RESEARCH-BASED DEGREE SUPERVISIONInvestigation of Novel Purinergic Therapeutics for the Treatment of Alzheimer’s Disease and Amyotrophic Lateral Sclerosis
- RESEARCH-BASED DEGREE SUPERVISIONMitochondria: An Emerging Therapeutic Target for Neurodegeneration
- RESEARCH-BASED DEGREE SUPERVISIONMolecules that modulate brain function